SFI — Sopharma Properties ADSITS Income Statement
0.000.00%
Last trade - 00:00
- BGN190.98m
- BGN189.45m
- BGN16.29m
- 78
- 30
- 33
- 42
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 11.6 | 11.3 | 12.7 | 14.6 | 16.3 |
Cost of Revenue | |||||
Gross Profit | 7.7 | 7.6 | 9.45 | 10.8 | 12.2 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4.08 | 4 | 3.43 | 4.17 | 4.28 |
Operating Profit | 7.53 | 7.31 | 9.26 | 10.4 | 12 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 7.19 | 7.04 | 9.07 | 10.3 | 11.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.19 | 7.04 | 9.07 | 10.3 | 11.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 7.19 | 7.04 | 9.07 | 10.3 | 11.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7.19 | 7.04 | 9.07 | 10.3 | 11.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.341 | 0.335 | 0.415 | 0.479 | 0.539 |
Dividends per Share |